Ionizable Amino‐Polyesters Synthesized via Ring Opening Polymerization of Tertiary Amino‐Alcohols for Tissue Selective mRNA Delivery

The utility of messenger RNA (mRNA) as a therapy is gaining a broad interest due to its potential for addressing a wide range of diseases, while effective delivery of mRNA molecules to various tissues still poses a challenge. This study reports on the design and characterization of new ionizable amino‐polyesters (APEs), synthesized via ring opening polymerization (ROP) of lactones with tertiary amino‐alcohols that enable tissue and cell type selective delivery of mRNA. With a diverse library of APEs formulated into lipid nanoparticles (LNP), structure‐activity parameters crucial for efficient transfection are established and APE‐LNPs are identified that can preferentially home to and elicit effective mRNA expression with low in vivo toxicity in lung endothelium, liver hepatocytes, and splenic antigen presenting cells, including APE‐LNP demonstrating nearly tenfold more potent systemic mRNA delivery to the lungs than vivo‐jetPEI. Adopting tertiary amino‐alcohols to initiate ROP of lactones allows to control polymer molecular weight and obtain amino‐polyesters with narrow molecular weight distribution, exhibiting batch‐to‐batch consistency. All of which highlight the potential for clinical translation of APEs for systemic mRNA delivery and demonstrate the importance of employing controlled polymerization in the design of new polymeric nanomaterials to improve in vivo nucleic acid delivery.

[1]  Daniel G. Anderson,et al.  Poly(β‐amino ester)‐co‐poly(caprolactone) Terpolymers as Nonviral Vectors for mRNA Delivery In Vitro and In Vivo , 2018, Advanced healthcare materials.

[2]  Robert Langer,et al.  Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse , 2017, Molecular therapy. Nucleic acids.

[3]  Qiang Cheng,et al.  Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers. , 2017, Biomacromolecules.

[4]  Daniel G. Anderson,et al.  Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing , 2017, Nature Biotechnology.

[5]  Jong-Min Lim,et al.  Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics , 2017, Nature Communications.

[6]  K. Kataoka,et al.  Virus‐Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo , 2017, Advanced materials.

[7]  Gaurav Sahay,et al.  Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA. , 2017, Nano letters.

[8]  Robert Langer,et al.  Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures , 2017, Expert opinion on drug delivery.

[9]  Özlem Türeci,et al.  Elimination of large tumors in mice by mRNA-encoded bispecific antibodies , 2017, Nature Medicine.

[10]  Daniel G. Anderson,et al.  Advances in the delivery of RNA therapeutics: from concept to clinical reality , 2017, Genome Medicine.

[11]  C. Villa,et al.  Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[12]  D. Weissman,et al.  Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge , 2017, Nature Communications.

[13]  I. Verma,et al.  Systemic delivery of factor IX messenger RNA for protein replacement therapy , 2017, Proceedings of the National Academy of Sciences.

[14]  Daniel G. Anderson,et al.  Materials for non-viral intracellular delivery of messenger RNA therapeutics. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Jing Hao,et al.  Progress towards the Synthesis of Amino Polyesters via Ring-Opening Polymerization (ROP) of Functional Lactones , 2016 .

[16]  Daniel G Anderson,et al.  Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs. , 2016, Angewandte Chemie.

[17]  Daniel G. Anderson,et al.  Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose , 2016, Proceedings of the National Academy of Sciences.

[18]  Özlem Türeci,et al.  Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy , 2016, Nature.

[19]  Kevin J. Kauffman,et al.  Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system , 2016, Gene Therapy.

[20]  Gaurav Sahay,et al.  Challenges in carrier-mediated intracellular delivery: moving beyond endosomal barriers. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[21]  O. Farokhzad,et al.  Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. , 2016, Chemical reviews.

[22]  P. Levkin,et al.  Combinatorial Approach to Nanoarchitectonics for Nonviral Delivery of Nucleic Acids , 2016, Advanced materials.

[23]  Daniel G. Anderson,et al.  Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo , 2016, Nature Biotechnology.

[24]  H. Fuchs,et al.  Clinical Chemistry Reference Intervals for C57BL/6J, C57BL/6N, and C3HeB/FeJ Mice (Mus musculus). , 2016, Journal of the American Association for Laboratory Animal Science : JAALAS.

[25]  Daniel G. Anderson,et al.  Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs. , 2015, Nano letters.

[26]  Yunfeng Yan,et al.  Rapid Synthesis of a Lipocationic Polyester Library via Ring-Opening Polymerization of Functional Valerolactones for Efficacious siRNA Delivery. , 2015, Journal of the American Chemical Society.

[27]  T. Schlake,et al.  Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals , 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  S. Beer-Hammer,et al.  In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency , 2015, Nature Biotechnology.

[29]  Daniel G. Anderson,et al.  Ionizable amphiphilic dendrimer-based nanomaterials with alkyl-chain-substituted amines for tunable siRNA delivery to the liver endothelium in vivo. , 2014, Angewandte Chemie.

[30]  M. Slevin,et al.  ENDOTHELIAL DYSFUNCTION AND INFLAMMATION , 2014 .

[31]  J. Kamps,et al.  A critical role for Egr-1 during vascular remodelling in pulmonary arterial hypertension. , 2014, Cardiovascular research.

[32]  Daniel G. Anderson,et al.  Non-viral vectors for gene-based therapy , 2014, Nature Reviews Genetics.

[33]  R. Waymouth,et al.  Organocatalytic ring-opening polymerization of morpholinones: new strategies to functionalized polyesters. , 2014, Journal of the American Chemical Society.

[34]  Robert Langer,et al.  Degradable Lipid Nanoparticles with Predictable In Vivo siRNA Delivery Activity , 2014, Nature Communications.

[35]  Daniel G. Anderson,et al.  In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight. , 2014, Nature nanotechnology.

[36]  Jon Christensen,et al.  Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae , 2014, Proceedings of the National Academy of Sciences.

[37]  Akin Akinc,et al.  Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles , 2013, Molecular therapy. Nucleic acids.

[38]  I. Zuhorn,et al.  Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis. , 2013, ACS nano.

[39]  Z. Rehman,et al.  How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[40]  P. Cullis,et al.  Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.

[41]  Daniel G. Anderson,et al.  Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity. , 2012, Biomaterials.

[42]  A. Dudley Tumor endothelial cells. , 2012, Cold Spring Harbor perspectives in medicine.

[43]  Xiabin Jing,et al.  Biodegradable synthetic polymers: Preparation, functionalization and biomedical application , 2012 .

[44]  J. Kamps,et al.  Targeted siRNA delivery to diseased microvascular endothelial cells—Cellular and molecular concepts , 2011, IUBMB life.

[45]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[46]  Zhaozhong Jiang,et al.  Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. , 2011, Nature materials.

[47]  M. Taljaard,et al.  Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): the first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction. , 2010, American heart journal.

[48]  G. Molema Heterogeneity in responses of microvascular endothelial cells during inflammation , 2010 .

[49]  K. G. Rajeev,et al.  Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  Kenneth J. Longmuir,et al.  Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis , 2009, Histochemistry and Cell Biology.

[51]  Philippe Lecomte,et al.  Recent advances in the synthesis of aliphatic polyesters by ring-opening polymerization. , 2008, Advanced drug delivery reviews.

[52]  Robert Langer,et al.  A combinatorial polymer library approach yields insight into nonviral gene delivery. , 2008, Accounts of chemical research.

[53]  S. Akhtar,et al.  Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity. , 2007, Advanced drug delivery reviews.

[54]  I. Zuhorn,et al.  Gene delivery by cationic lipids: in and out of an endosome. , 2007, Biochemical Society transactions.

[55]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[57]  A. Hochberg,et al.  Regulatory sequences of H19 and IGF2 genes in DNA‐based therapy of colorectal rat liver metastases , 2005 .

[58]  R. Budhiraja,et al.  Endothelial Dysfunction in Pulmonary Hypertension , 2004, Circulation.

[59]  M. Conese,et al.  Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs , 2000, Gene Therapy.

[60]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.